Form 4 for NUVB Nuvation Bio Inc.
Accepted 2025-10-29 00:00:00 ET · period of report 2025-10-27 · accession 0001521111-25-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-10-29 | 2025-10-27 | NUVB | Hattersley Gary | CSO | S - Sale+OE | $5.02 | -100.0K | 0 | -100% | -$502.0K |
| D | 2025-10-29 | 2025-10-27 | NUVB | Hattersley Gary | CSO | M - OptEx | $1.74 | +100.0K | 100.0K | New | +$174.0K |
| D | 2025-10-29 | 2025-10-27 | NUVB | Hattersley Gary | CSO | M - OptEx | $0.00 | -100.0K | 298.9K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2025-10-27 | S | D | 100,000 | $5.02 | 0 | D | — | — | (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Class A Common Stock | 2025-10-27 | M | A | 100,000 | $1.74 | 100,000 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-10-27 | M | D | 100,000 | $0.00 | 298,935 | D | $1.74 · — to 2030-01-21 | 100,000 Class A Common Stock | (F3) Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years. |